Author Correction: Classification of GBA1 variants and their impact on Parkinson's disease: an in silico score analysis

Affiliations

• ¹ Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France. aymeric.lanore@icm-institute.org.
• ² Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France. aymeric.lanore@icm-institute.org.
• ³ Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Assistance Publique Hôpitaux de Paris, NS-Park/FCRIN network, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
• ⁴ Assistance Publique Hôpitaux de Paris, Department of Neurology, CIC Neurosciences, Hôpital Pitié-Salpêtrière, Paris, France.
• ⁵ CAP-HP, Hôpital Pitié Salpêtrière, Centre de Pharmacoépidémiologie (Cephepi), Paris, France.
• ⁶ Department of Neurology, Neurogenetic Reference Centre, Parkinson's Expert Centre, University Hospitals of Strasbourg, Strasbourg, France.
• ⁷ Assistance Publique Hôpitaux de Paris, Sleep disorders unit, Hôpital Pitié-Salpêtrière, Paris, France.
• ⁸ Neurology Department, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, Poitiers, NS-PARK/FCRIN Network, France.
• ⁹ Hôpital Fondation Ophtalmologique A de Rothschild, Unité James Parkisnon, NS-PARK/FCRIN Network, Paris, France.
• ¹⁰ Clinical Investigation Center CIC1436, Parkinson Expert Center, Department of Clinical, Pharmacology and Neuroscience, NS-Park/FCRIN network, NeuroToul COEN Center; Toulouse, University Hospital, INSERM and University of Toulouse 3, Toulouse, France.
• ¹¹ Parkinson's Disease Center of Excellence, Department of Neurology, University of Lille, CHU Lille, INSERM U1172- Degenerative & Vascular Cognitive Disorders, Lille, France.
• ¹² Pontchaillou University Hospital, Department of Neurology, CIC INSERM 1414, Rennes, France.
• ¹³ Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, Rennes, France.
• ¹⁴ Neurology Department, NS-Park/FCRIN network, Centre Hospitalier Universitaire de Nice, Université Côte d'Azur, Nice, France.
• ¹⁵ Assistance Publique Hôpitaux de Paris, Department of Neuroradiology, Hôpital Pitié-Salpêtrière, Paris, France.
• ¹⁶ Université Clermont Auvergne, IGCNC, Department of Neurology, Parkinson expert center, CHU Clermont-Ferrand, Clermont-Ferrand, France.
• ¹⁷ Department of Medical Pharmacology, CHU Lille, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR-S1172, LICEND, NS-Park/F-CRIN network, Lille, France.
• ¹⁸ Grenoble Alpes University, Movement Disorders Unit, Division of Neurology, CHU de Grenoble, Grenoble Institute of Neurosciences, Grenoble, France.
• ¹⁹ Hospices Civils de Lyon, Hôpital Neurologique Pierre Wertheimer, Department of Neurology C, NS-Park/FCRIN network, Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France; INSERM, Centre de Recherche en Neurosciences de Lyon, PATH-PARK, Bron, France.